Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy AzurRx BioPharma stock

Learn how to easily invest in AzurRx BioPharma stock.

AzurRx BioPharma Inc is a biotechnology business based in the US. AzurRx BioPharma shares (AZRX) are listed on the NASDAQ and all prices are listed in US Dollars. AzurRx BioPharma employs 12 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in AzurRx BioPharma

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – AZRX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

AzurRx BioPharma stock price (NASDAQ: AZRX)

Use our graph to track the performance of AZRX stocks over time.

AzurRx BioPharma shares at a glance

Information last updated 2022-01-16.
52-week range$1.82 - $22.50
50-day moving average $4.94
200-day moving average $7.50
Wall St. target price$16.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-15.49

Buy AzurRx BioPharma shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
M1 Finance
Free 1-year trial of M1 Plus
when you sign up for M1 Finance
Invest in your favorite stocks or in curated portfolios with automatic rebalancing.
SoFi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stash Invest
Stocks, ETFs
$1 per month
Add at least $5 to your Invest account
Stash is more than an investment app. You’ll have access to tools that can help you become a confident investor.
Stocks, ETFs, Cryptocurrency
$0 per month
Download and sign up with; approved accounts receive a free stock slice worth up to $300, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy AzurRx BioPharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

AzurRx BioPharma price performance over time

Historical closes compared with the close of $N/A from 2021-12-08

1 week (2022-01-16) N/A
1 month (2021-12-23) N/A
3 months (2021-10-23) N/A
6 months (2021-07-27) -100.00%
1 year (2021-01-27) -100.00%
2 years (2020-01-27) -100.00%
3 years (2019-01-25) -100.00%
5 years (2017-01-27) -100.00%

AzurRx BioPharma financials

Gross profit TTM $0
Return on assets TTM -233.79%
Return on equity TTM -1271.87%
Profit margin 0%
Book value $0.85
Market capitalisation $34.4 million

TTM: trailing 12 months

AzurRx BioPharma share dividends

We're not expecting AzurRx BioPharma to pay a dividend over the next 12 months.

Have AzurRx BioPharma's shares ever split?

AzurRx BioPharma's shares were split on a 1:10 basis on 12 September 2021. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your AzurRx BioPharma shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for AzurRx BioPharma shares which in turn could have impacted AzurRx BioPharma's share price.

AzurRx BioPharma share price volatility

Over the last 12 months, AzurRx BioPharma's shares have ranged in value from as little as $1.82 up to $22.5. A popular way to gauge a stock's volatility is its "beta".

AZRX.US volatility(beta: 1.51)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while AzurRx BioPharma's is 1.5109. This would suggest that AzurRx BioPharma's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

AzurRx BioPharma overview

AzurRx BioPharma, Inc. , a clinical stage biopharmaceutical company, focuses on the development of recombinant proteins for the treatment of gastrointestinal diseases. Its therapeutic products administer patients as oral non-systemic biologics. The company's lead therapeutic is MS1819, a recombinant lipase for the treatment of exocrine pancreatic insufficiency. It is also developing two clinical programs using proprietary formulations of niclosamide, a pro-inflammatory pathway inhibitor, including FW-420, for grade 1 Immune Checkpoint Inhibitor-associated colitis and diarrhea in oncology patients; and FW-1022, for COVID-19 gastrointestinal infections. AzurRx BioPharma, Inc. has a license agreement with First Wave Bio, Inc.

AzurRx BioPharma in the news

There are no recent company news

Frequently asked questions

What percentage of AzurRx BioPharma is owned by insiders or institutions?
Currently 0.767% of AzurRx BioPharma shares are held by insiders and 5.821% by institutions.
How many people work for AzurRx BioPharma?
Latest data suggests 12 work at AzurRx BioPharma.
When does the fiscal year end for AzurRx BioPharma?
AzurRx BioPharma's fiscal year ends in December.
Where is AzurRx BioPharma based?
AzurRx BioPharma's address is: 777 Yamato Road, Boca Raton, FL, United States, 33431
What is AzurRx BioPharma's ISIN number?
AzurRx BioPharma's international securities identification number is: US33749P1012
What is AzurRx BioPharma's CUSIP number?
AzurRx BioPharma's Committee on Uniform Securities Identification Procedures number is: 05502L105

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site